Corticosteroids and bone mass in asthma SIR,-Dr G J Addis (7 March, p 644) is concerned that we should respond to Dr G K Crompton's thoughtful criticism (10 January, p 123) of our paper (6 December 1986 (6 December , p 1463 .
In his letter Dr Crompton drew attention to the difficulties of obtaining detailed information retrospectively from hospital records and expressed the belief that some of the patients studied who were under his own care may have received additional courses of systemic corticosteroids that were not recorded. As Dr Crompton is a close colleague working in a neighbouring unit that was collaborating in our study our initial response was to ask him to make his own independent assessment of the corticosteroid intake of the patients concerned. Subsequently, however, Dr Addis's letter has prompted us to review ourselves, as carefully as possible, the case records of those patients in group 3 who were classified as having received only inhaled steroids, with or without short booster courses of systemic corticosteroids, and to supplement this information with information obtained from the patients themselves and, in some cases, their general practitioners.
Twenty out of 22 case records were traced, and four discrepancies have been ascertained. One man .(aged 21) who was classified as having received no oral corticosteroids was found to have received intermittent systemic corticosteroids for several years before total body calcium was measured, although not in the two years immediately before bone mass was estimated. Exclusion of this patient from the group leaves a total of 21 patients (10 men and 11 women), with a mean (SD) age of 57-2 (10-2) years. Compared with the 40 normal controls, mean total body calcium was still reduced by 8-4% (p<0-001). Three discrepancies were found in the calculation of the number of booster courses of oral corticosteroids. Two men, previously classified as not having received any, had in fact received two and one 10 day booster courses of steroids. Another man thought to have had only one booster course seems to have had at least five, and five of the patients treated with both inhaled steroids and booster courses had in fact taken higher doses of inhalation steroids for short periods. Clearly, it is impossible in a retrospective study of this kind to determine the relative importance of the inhaled corticosteroids and the intermittent short booster courses of systemic steroids in the associated reduction in total bone mass, but a recent study of bone metabolism during methylprednisolone pulse treatment in rheumatoid arthritis failed to show a significant effect. ' Dr Crompton also questions the possibility that the differences in total body calcium between those patients who had never received corticosteroid treatment (group 4) and those treated with inhaled corticosteroids with or without booster courses of systemic steroids (group 3) could partly be explained by their differences in mean age. As stated in the paper, we do not believe this to be the case as previous studies of total body calcium in normal subjects have failed to show a relation between bone mass and age in men or premenopausal women.2 Demographic details of normal subjects and the derivation of the normal range for total body calcium have been published,3 and details were therefore not included in this paper.
While Dr Crompton may well be correct in believing that patients with asthma apparently controlled with inhaled corticosteroids alone require short booster courses of systemic corticosteroids more often than is always apparent, our data do suggest that patients treated in this way may suffer some reduction in total bone mass. The only way to be certain whether it is the inhaled corticosteroids, the intermittent booster courses of systemic corticosteroids, or the combination of both that is responsible is to undertake prospective studies.
D The absence of laparoscopic evidence in most cases in the study by Dr Jacob and colleagues therefore leaves the proportion of true cases of pelvic inflammatory disease open to question and means that their study cannot be compared with others in which this examination was done routinely. Furthermore, we wonder about the relevance of the chlamydial investigations performed by Dr Jacob and coworkers. As the relation of Chlamydia trachomatis in the cervices of their patients to pelvic inflammatory disease is unknown and as they do not comment on the relation between chlamydial infections in the women and those in the male partners the value of such tests is not clear. What is clear is that many male contacts had non-gonococcal urethritis, often without symptoms. Ofcourse, this is probably true ofthe male partners ofmany groups ofwomen with infections ofthe genital tract, and to advise that the sexual contacts ofwomen with pelvic inflammatory disease should be sought and treated goes without saying.
C Surely it must be questioned whether such subjective judgments can form the basis for a reliable estimate of the prevalence of ill health in any section of the community. Furthermore, unemployment is a demoralising state that would probably enhance any negative feelings an individual has about his or her health and thus give rise to further bias.
Mortality ratios are another matter. But I would suggest that it is better to concentrate on and try to evaluate the extent of the known and at present accepted causes of ill health-inherited factors, bad housing, smoking, alcohol abuse, inappropriate diet, and lack of exercise-and the relation of these to ill health. Surveys directed to such matters are more likely to throw light on the prevalence and causation of ill health and might in the longer term help point the way to how these factors can best be influenced to the benefit of the health of the community.
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